Clinical safety of combined therapy of immune checkpoint inhibitors and Viscum album L. therapy in patients with advanced or metastatic cancer

Abstract Background Despite improvement of tumour response rates in patients with progressive and metastatic cancer, immune checkpoint inhibitors (ICM) induce toxicities in cancer patients. Viscum album L. (VA, mistletoe) extracts are applied as add-on cancer therapy especially in German speaking co...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Anja Thronicke, Megan L. Steele, Christian Grah, Burkhard Matthes, Friedemann Schad
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	BMC 2017-12-01
Cyfres:	BMC Complementary and Alternative Medicine
Pynciau:	Targeted therapy Immune checkpoint inhibitors PD-1 CTLA-4 Mistletoe Viscum album L.
Mynediad Ar-lein:	http://link.springer.com/article/10.1186/s12906-017-2045-0
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!